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ABSTRACT: Supplementation of bovine colostrum (BC) has shown to improve growth performance, intes-
tinal development, and immune response in early-weaned pigs. Little is known about whether BC may have 
similar effects in neonatal piglets. In the present study, the effect of BC supplementation on mortality, growth 
performance, and blood parameters (plasma proteins and white blood count) of suckling piglets in the first 
10 days of life was investigated under practical conditions with special emphasis on low birth weight piglets. In 
total, 258 newborn piglets from 30 multiparous sows in a commercial breeding unit were randomly assigned to 
two different treatment groups. Piglets received either 1 ml of BC orally on days 1–3 of life (group BC, n = 128) 
or 1 ml of saline (0.9%) (control (CON) group; n = 130). Body weight was measured on days 1, 4, and 10 of life. 
Blood was collected on days 1 and 4 from 60 piglets per group. No differences in mortality, body weight, and 
average daily weight gain were observed between treatment groups in days 1–10. However, compared to CON, 
particularly in low birth weight piglets the administration of BC supported (P < 0.01) their survival. Group BC 
exhibited lower plasma total protein (P = 0.03) and beta-globulin (P = 0.02) concentrations compared to group 
CON. In conclusion, BC improved low and normal birth weight piglets’ survival during their first 10 days of 
life. Further research is needed to clarify whether the survival rate is related to earlier gut closure indicated by 
lower plasma protein levels, which might be beneficial due to a lower uptake of potential antigenic substances.
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INTRODUCTION
Neonatal mortality is estimated at around 10% 
in livestock animals (Sangild 2003) and represents 
one of the major economic losses in pig rearing 
systems. Pre-weaning mortality mostly occurs 
during the first days of life (Tuchscherer et al. 
2000) and insufficient colostrum intake leads to 
an increased risk of starvation (Jensen et al. 2001). 
Sow’s colostrum provides piglets with energy for 
thermoregulation (Le Dividich et al. 2005), im-
mune protection (Klobasa et al. 1981), and pro-
motes intestinal development (Xu et al. 2000). In 
modern pig production, selection on prolificacy 
substantially increases numbers of life-born piglets, 
but also concurs with a greater heterogeneity in 
birth weights and lower vitality of piglets (Devil-
lers et al. 2011). Since colostrum production is 
highly variable among sows and independent of 
litter size (Devillers et al. 2007), ensuring a suf-
ficient colostrum uptake by all piglets emerged 
to be a major challenge. In addition, colostrum 
intake depends not only on the amount the sows 
are capable to produce, but low birth weight and 
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vitality also impact piglet’s ability to extract co-
lostrum from teats (Hoy et al. 1997). Increasing 
litter sizes lead to decreased piglets’ average birth 
weights (Devillers et al. 2011); and low birth weight 
piglets show lower thermoregulatory abilities 
(Herpin et al. 2002), are less vigorous competing 
with heavier littermates, and are often crushed by 
the sow (Rutherford et al. 2013). Additionally, low 
birth weight is associated with various negative 
long-term effects like higher disease susceptibility 
due to an insufficient immunity acquirement as a 
result of the delayed or restricted suckling after 
birth (Rutherford et al. 2013). 
Bovine colostrum (BC) is a co-product of the 
dairy industry which contains highly available nu-
trients and bioactive molecules such as growth and 
anti-microbial factors (Pakkanen and Aalto 1997) 
and is particularly promoted by the feed industry 
to promote weak and low birth weight piglets as 
well as piglets from big litters. BC comprises high 
levels of immunoglobulins (Ig) and growth factors 
such as IGF-1 (de Lange et al. 2010) and contained 
whey proteins may exert immune-modulatory abil-
ity as they were recognized as potent modulators 
of cellular immune function in livestock species 
(Boudry et al. 2008b). Beneficial aspects of BC 
on growth performance, intestinal development, 
immune parameters, and sanitary status of pigs 
during the early post-weaning period have been 
already demonstrated (King et al. 2007; Huguet et 
al. 2011). Additionally, positive effects of BC on the 
incidence of necrotizing enterocolitis in preterm 
piglets were described previously (Bjornvad et al. 
2008, Jensen et al. 2013). Although effects of BC 
have been well described for the post-weaning 
phase, less information is available for piglet’s 
survival, growth performance, and immune status 
during the early suckling phase, especially for low 
birth weight piglets, when the piglet largely relies 
on the immunity of the sow. Under practical con-
ditions, recommended dosages of commercially 
available BC supplements for neonatal piglets are 
much lower than doses tested under experimental 
conditions (Bridger and Brown 1981; Bjornvad 
et al. 2008; Jensen et al. 2013). In this study the 
effect of commercially available BC was tested 
when provided at a dose typically administered to 
newborn piglets by farmers. It was hypothesized 
that already relatively low doses of supplementary 
BC would promote piglet immunity and growth, 
thereby would decrease neonatal mortality, espe-
cially in less vital and low birth weight piglets. In 
the present pilot study a commercially available 
BC product was administered to newborn piglets 
under field conditions to assess potential effects 
onto piglet survival rates, growth rates, occurrence 
of diarrhea, and changes in white blood count and 
Ig in low and normal birth weight piglets. 
MATERIAL AND METHODS
The experimental protocol used in this study has 
been approved by the German State Agency for 
Agriculture, Food Safety and Fishery Mecklenburg-
Western Pomerania (Certificate No. 7221.3-1.1-
081/12).
Animals and experimental design. A total of 
258 newborn piglets ((Landrace × Large White) × 
Piétrain) from 30 multiparous sows of a commercial 
pig breeding farm in Mecklenburg-Western Po-
merania, Germany, were included in this study. Sows 
were housed in groups during mating and gestation 
and were moved to farrowing pens (with individual 
farrowing crates) seven days prior to the expected 
farrowing date. Sows were fed commercial gestation 
and lactation diets. Water was provided via nipple 
drinkers ad libitum. On day 114 of gestation, sows 
were injected intramuscularly with 0.7 ml of a syn-
thetic prostaglandin analogue (Estrumate 250 µg/ml; 
Intervet GmbH, Unterschleissheim, Germany) to 
induce parturition within the next 24 h. Farrowing 
pens were diffusely ventilated with a room tempera-
ture of 18–21°C. Heating plates were provided for 
the piglets at one side of the pen next to the sow. 
Parturitions were monitored, but interference was 
kept at a minimum. Piglet performance was followed 
from birth until day 10 of life. Immediately after 
birth, all piglets per litter were weighed and 8 ± 1.74 
(SD) piglets per litter, depending on litter size, were 
randomly assigned to one of the two treatment groups 
and individually marked with ear tags. Piglets in 
group BC (n = 128) received 1 ml of bovine colostrum 
preparation orally (Vetilan COLOSTRUM BOOST; 
Veracus GmbH, Bremerhaven, Germany) on three 
consecutive days (1 ml/piglet on days 1, 2, and 3 of 
life), while piglets in group CON (n = 130) served as 
negative control receiving sterile saline orally (1 ml 
0.9% NaCl/piglet on days 1, 2, and 3 of life). Vetilan 
COLOSTRUM BOOST is a product licensed to be 
fed to weak and small piglets immediately after birth 
and, if needed, every 24 h thereafter (1–2 ml  per 
piglet). According to the manufacturer’s specifica-
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tion, it consists of 100% sterile filtered, de-fatted, 
and de-caseinated bovine colostrum containing 
more than 20% immunoglobulins. Piglets were not 
cross-fostered so that litters were kept together 
regardless of their size. All piglets were allowed to 
suckle their dams at any time of the day and received 
an injection of iron intramuscularly (1 ml/pig Urso-
ferran 200 mg/ml; MEDISTAR Arzneimittelvertrieb 
GmbH, Bernburg, Germany) on day 4 of life. Body 
weight of all piglets was recorded on days 1, 4, and 
10 of life. Blood samples (groups BC and CON: n = 
60; 1–2 ml blood/piglet) of the two heaviest piglets 
of the same litter from each treatment group were 
taken by puncture of the anterior vena cava on days 1 
and 4 of life. The samples were collected into EDTA 
tubes (KABE®, Nuembrecht-Elsenroth, Germany). 
The heaviest piglets were selected for blood collec-
tion to minimize the possibility of missing samples 
on day 4 due to animal losses. Throughout the ex-
perimental period (days 1–10), piglets were daily 
examined for signs of diarrhea and the number of 
dead piglets was recorded.
Chemical analysis. Cytological and biochemi-
cal blood analyses were performed according to 
routine methods. Complete blood counts includ-
ing white blood count (WBC) were determined in 
both groups of piglets in an automatic cell coun-
ter (MEK-6108G; Nihon Kohden Europe GmbH, 
Rosbach, Germany). Differential cell counts were 
determined by counting of 200 cells in blood smears 
after Pappenheim staining. Total protein concentra-
tion was determined photometrically by biurette 
method. Blood samples were centrifuged at 2000 g 
for 15 min and plasma was stored at –20°C until 
further analysis. Plasma protein contents (total 
protein, albumin, alpha-1-, alpha-2-, beta-, and 
gamma-globulin) were determined by plotting 
the EDTA plasma onto a cellulose acetate film 
(Elphor, Sarstedt AG & Co., Nuembrecht-Rom-
melsdorf, Germany) and proteins were separated in 
an electric field according to their size and charge 
by electrophoresis using an integrated scanning 
system Elphoscan Mini Plus (Sarstedt AG & Co.).
Statistical analyses. To compare differences 
between treatment groups, data were subjected to 
ANOVA using the PROC MIXED of SAS (Statistical 
Analysis System, Version 9.2, 2009). 
To investigate the effect of BC supplementation, 
fixed effects in the model included the main ef-
fects of BC supplementation and sex as well as the 
random effect of sow, considering the pig as the 
experimental unit. The day of the experiment when a 
piglet died was used to estimate the piglet’s survival 
time. To estimate whether plasma parameters were 
different at the two sampling days, data collected 
on the same pig and two sampling days were con-
sidered as spatial repeated measures. The covari-
ance structure was modelled separately according 
Table 1. Effect of bovine colostrum supplementation on survival time and growth performance of suckling piglets in 
days 1–10 of life
Parameter
Group BC Group CON Pooled  
SEM P-valuemean n mean n
Days of life of piglets that died during days 1–10 
All piglets 5.7a  15 2.8b  12 0.53 0.002
25% low birth weight piglets 5.7a  15 2.4b 9 8.90 0.001
Initial BW (kg)
All piglets 1.4 118 1.4 128 0.04 0.726
25% low birth weight piglets 0.9 32 0.9 27 0.03 0.642
Final BW (kg)
All piglets 3.0 103 3.0 115 0.09 0.449
25% low birth weight piglets 2.5 16 2.3 26 0.11 0.484
ADG days 1–10 (g/day)
All piglets 153.7 103 154.8 115 6.53 0.904
25% low birth weight piglets 110.1 16 120.6 26 17.91 0.685
group BC = Vetilan COLOSTRUM BOOST administration on days 1–3 of life, group CON = control, with 0.9% NaCl admin-
istration on days 1–3 of life, BW = body weight, ADG = average daily gain
data are presented as Least Squares Means ± SEM
a,bvalues with different superscripts differ significantly at P < 0.05
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to the smallest values of the fit statistics based on 
the Bayesian information criteria (BIC). Means 
were reported as Least Squares Means ± standard 
error of the mean (SEM) with P ≤ 0.05 defined as 
significant and 0.05 < P ≤ 0.10 as trends. Degrees of 
freedom were approximated using Kenward-Rogers 
method (ddfm = kr). To investigate whether BC 
supplementation affected particularly weak piglets, 
25% of piglets with the lowest birth weight of each 
treatment group were analyzed separately. Pearson’s 
correlation coefficients among variables of blood 
parameters and body weights at birth and at days 4 
and 10 of life were determined using PROC CORR.
RESULTS
The present sows delivered on average 12.93 ± 2.76 
(SD) piglets per litter with 34 out of 258 (i.e. 13.2%) 
piglets weighing less than 1.0 kg at birth. Litters of 
16 or more siblings (two sows with n = 16 piglets, 
three sows with n = 17, n = 18, and n = 20 piglets 
each) existed and piglets were not cross-fostered. 
Mortality. During their first 10 days of life, 28 out 
of 246 (11.4%) study piglets died due to different 
reasons. Mortality was not different between treat-
ment groups (group BC, n = 15 (12.7%), group CON, 
n = 13 (10.2%); P = 0.72, SEM = 0.13). Days of life of 
piglets of the two different groups that died in the 
experimental period are displayed in Table 1. With 
BC intake, the piglets that died within the experi-
mental period were by 3 days longer alive than the 
piglets of CON group (P < 0.01). In piglets with a 
very low birth weight, BC supplementation signifi-
cantly prolonged their life during the first 10 days 
of life compared to piglets of CON group (Table 1).
Animal growth performance and sanitary status. 
Piglet body weight did not differ between the two 
treatment groups on days 1, 4, and 10 of life (P ≥ 
0.45). Likewise, average daily gain (ADG) was similar 
between treatments, being 153.7 g/day ± 6.69 (SEM) 
and 154.8 g/day ± 6.37 (SEM) for group BC and CON 
(P = 0.90), respectively (Table 1). Also, the piglets by 
25% lower in birth weight had similar body weight 
(P > 0.48) and ADG (P = 0.69) in both treatment 
groups. Regardless of the treatment group, around 
30% of the piglets showed mild to severe diarrhea 
during the experimental period (days 1–10 of life). 
Hematological parameters. Blood samples were 
collected from piglets in groups BC (n = 60) and 
CON (n = 60) on day 1 and from the same piglets 
on day 4 of life with 54 out of 60 suitable sera for 
analysis in both treatment groups. Mean WBC 
values of both treatment groups are presented in 
Table 2. In piglets which received BC a tendency 
Table 2. Hematological parameters of groups BC and 
CON piglets at days 1 and 4 of life






Day 1 12.3 13.0 0.80 0.239
Day 4 10.5A 9.7B 0.38 0.069
group BC = Vetilan COLOSTRUM BOOST administration 
on days 1–3 of life (n = 54), group CON = control, with 0.9% 
NaCl administration on days 1–3 of life (n = 54), WBC = 
white blood count
data are presented as Least Squares Means ± pooled SEM
A,Bvalues with different superscripts demonstrate trends at 
P < 0.1 > 0.05
Table 3. Serum proteins of group BC and CON piglets at 










Day 1 52.7 53.5 3.00 0.651
Day 4  58.7a  62.4b 1.39 0.032
Albumin 
Day 1 6.7 6.7 0.32 0.650
Day 4 13.6A 14.3B 0.41 0.085
Alpha-1 
Day 1 2.0 2.0 0.11 0.600
Day 4   1.8A   2.0B 0.06 0.076
Alpha-2
Day 1 6.0 6.2 0.44 0.681
Day 4 8.8 9.0 0.28 0.570
Beta
Day 1 7.4 8.0 0.41 0.208
Day 4 11.6a 12.6b 0.47 0.018
Gamma 
Day 1 30.4 30.6 2.77 0.913
Day 4 22.9 24.5 0.94 0.155
group BC = Vetilan COLOSTRUM BOOST administration 
on days 1–3 of life (n = 55), group CON = control, with 0.9% 
NaCl administration on days 1–3 of life (n = 57)
data are presented as Least Squares Means ± pooled SEM
a,bvalues with differnet superscripts differ significantly at P < 0.05
A,Bvalues with different superscripts demonstrate trends at 
P < 0.1 > 0.05
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towards an increase in WBC (P = 0.07) compared to 
piglets of group CON on day 4 (Table 2) was seen. 
Plasma proteins. Total protein, albumin, alpha-1-, 
alpha-2-, beta-, and gamma-globulin were deter-
mined in 55 and 57 blood samples collected from 
60 piglets in groups BC and CON on days 1 and 4 
of life, respectively. From days 1 to 4, total protein, 
albumin, alpha-2-, beta-globulin increased and 
alpha-1- and gamma-globulin decreased for both 
groups. Group BC piglets had lower total protein 
(P = 0.03) and beta-globulin (P = 0.02) concentra-
tions and, as trend, lower albumin (P = 0.09) and 
alpha-1 (P = 0.08) concentrations compared to 
group CON piglets on day 4 of life (Table 3). In 
both groups (BC and CON), a significant correla-
tion was found between the protein concentration 
and the concentration of gamma-globulins at birth 
(r = 0.96, P < 0.001) and between body weight (BW) 
on day 10 and the protein concentration at birth 
(group BC: r = 0.45, P < 0.001, group CON: r = 
0.27, P = 0.04). In contrast, significant negative 
correlations (r = –0.4– –0.29, P < 0.05) were found 
for alpha-1-globulin concentrations on days 1 and 4 
with BW on days 4 and 10, respectively. 
DISCUSSION
In modern pig production, numerous offspring 
is an economic trait leading to increased numbers 
of piglets born per litter over the last decades. 
Hyper-prolific sows with more than 16 live-born 
piglets per litter often have a greater heterogeneity 
in piglet birth weight and a higher number of weak 
piglets at birth (Devillers et al. 2011), which was 
confirmed by the litter size and number of low weight 
piglets in the present study. It is widely recognized 
that pre-weaning mortality is positively correlated 
with litter size (Dyck and Swierstra 1987) and still 
remains an unsolved problem. Low birth weight is 
unanimously associated with reduced chances of 
survival (Cabrera et al. 2012) and thus increasing 
survival rates of vulnerable piglets is one of the big-
gest challenges. As causes for pre-weaning deaths 
are various and low colostrum intake is probably the 
most influential one, in this study, a commercially 
available BC product at a dosage typically used at 
pig breeding farms was supplemented to newborn 
piglets with special emphasis on low birth weights. 
Weak piglets, among those very low birth weight 
piglets, generally have a lower colostrum intake 
(Devillers et al. 2007) and early assistance is par-
ticularly beneficial to promote their survival. Here, 
we could show that piglets, including low birth 
weight piglets, have benefited from the extra BC 
in terms of a longer survival indicating that their 
colostrum intake might have been insufficient or 
that the amount of bioactive substances ingested 
with sow colostrum might have been too low to 
meet their special nutrient needs. According to 
the product declaration, the recommended BC 
dosage is 1–2 ml per piglet, which is much less 
than previously reported BC ranges in research 
studies (Bridger and Brown 1981; Gomez et al. 
1998; Moller et al. 2011; Huang et al. 2012). Taking 
into account, that sow-reared piglets consume on 
average 250–300 g/kg birth weight colostrum dur-
ing the first 24 h after birth (Quesnel et al. 2012), 
the recommended administration level of BC was 
most likely not high enough to clearly enhance 
piglet growth and survival. Several colostrum 
supplements, bovine and swine, are marketed, 
but scientific evidence on their effectiveness is 
sparse and natural colostrum seems to be superior 
to enriched formulae (Baxter et al. 2013). It was 
found that neither supplementation with 15 ml of 
sow colostrum (combined with cross-fostering) 
(Muns et al. 2014), nor 2 × 25 ml of sow colostrum 
(without continued aftercare) did improve piglets’ 
survivability (Muller et al. 2012) illustrating the 
multifactorial nature of piglet mortality. By giving 
piglets 12 ml of first milking BC, a reduction in 
pre-weaning mortality could be demonstrated by 
White et al. (1996). However, in the study of White 
et al. (1996) the BC supplementation was only 
one part of a multifaceted farrowing management 
protocol (White et al. 1996). In our study, a single 
dose of the tested BC on day 1 of life did not result 
in any beneficial effects on mortality, body weight, 
average daily weight gain, nor viability (data not 
shown), but despite the relatively small amount of 
BC used, repeated supplementation on days 1–3 
of life did influence piglets’ survivability (normal 
and low birth weights). The observed beneficial 
effects of BC may have been therefore cumula-
tive in piglets and it needs to be verified whether 
a higher dosage or a longer administration time 
of the commercial BC product might prevent the 
death of weak newborn piglets during the suckling 
phase. Overall, the present mortality rate of about 
12% was in the range of pre-weaning mortality in 
piglets previously described (Devillers et al. 2011) 
and was not influenced by BC administration.
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Compared with high birth weight littermates, 
light born piglets are disadvantaged in extracting 
colostrum from teats (Hoy et al. 1997). Nonetheless, 
sow’s colostrum is crucial for piglet’s energy supply 
needed for thermoregulation (Le Dividich et al. 
2005) and glucose homeostasis (Herpin et al. 1992) 
as piglets are born without fat stores (Le Dividich et 
al. 1991). The nutritional importance of colostrum 
for the survival and body growth of newborn pigs is 
e.g. indicated by the high digestibility of proteins in 
porcine colostrum of up to 100% (Lin et al. 2009). 
Jensen et al. (2001) demonstrated a considerable 
uptake of bovine macromolecules from cow’s colos-
trum in newborn piglets during the first 12 h after 
birth (Jensen et al. 2001). Although BC intake was 
comparatively small in the present study, piglets 
with very low birth weight may have profited most 
from the extra energy intake by BC administration 
enhancing their suckling capacity, which might have 
been indicated by the longer survival. However, in 
considering the daily administration dose, it may 
be rather assumed that the nutritional effect of BC 
may be of lower importance in the present field 
study, particularly because piglets could suckle 
freely during the experimental period. Therefore, 
it was not surprising that BW and ADG of normal 
and low birth weight piglets were similar among 
treatment groups. 
Several studies showed a direct correlation be-
tween newborn mortality and plasma IgG con-
centrations (Klobasa et al. 1981; Cabrera et al. 
2012). In the present study, the positive correlation 
between first-day protein concentrations and BW 
on day 10 implicates the necessity for uptake of 
energy and maternal proteins as the basic prereq-
uisite for piglet vitality and growth-performance 
in its future life. Regarding the plasma protein 
content, a similar increase in total protein, albu-
min, alpha-2-, and beta-globulin was found from 
day 1 to 4 of life for all piglets, independently of 
the BC administration, surpassing the essential 
threshold level of IgG of 10 mg/dl previously sug-
gested (Machado-Neto et al. 1987; Carbrera et al. 
2012). Due to the epitheliochorial placentation, 
piglets are born without systemic immunity in 
form of Ig and disease resistance mainly relies 
on an adequate colostrum and IgG uptake (Por-
ter 1969; Coalson and Lecce 1973; Klobasa et al. 
1981; Sangild 2003). Colostrum and milk offer 
both, high amounts of maternal cells (B and T 
cells) and other substances e.g. cytokines modulat-
ing offspring’s immunity (Wagstrom et al. 2000). 
Typically, neonatal piglets preferentially absorb 
porcine IgG relative to bovine IgG (Jensen et al. 
2001). Although absorption of bovine Ig cannot 
provide a noteworthy passive immunity against 
pig pathogens, piglet survival has been reported to 
benefit from bovine Ig supplementation compared 
to being fed milk replacer completely devoid of 
Ig (Gomez et al. 1998). These results suggest that 
colostrum per se may contain nutrients and bioac-
tive factors positively affecting disease resistance 
in a species-independent manner (Sangild 2003), 
which may be related to innate immunity receptor 
compatibilities and antibody specificity targeted 
at pathogen associated molecular patterns cover-
ing also microbe associated molecular patterns of 
sows’ indigenous microbiota, respectively. Interest-
ingly, in the present study, a decrease in plasma 
protein levels (total protein, albumin, alpha-1- and 
beta-globulin) was found in BC supplemented 
piglets compared to control piglets. Because the 
supplemented BC was only a small part of the 
overall colostrum consumption of the piglet, the 
reason for the lower protein levels with BC sup-
plementation might be related to a reduction in gut 
permeability triggered by the extra BC consump-
tion and thus might hint at an earlier gut closure 
of piglets receiving BC compared to the control 
piglets as previously demonstrated by Jensen et 
al. (2001). Albumin is one of the major porcine 
colostral proteins (Gallagher et al. 1997) and the 
absorption of bovine serum albumin by neonatal 
pigs has been previously described (Westrom et 
al. 1984; Huang et al. 2012). Plasma beta-globulin 
contains, among others, the acute-phase-protein 
(APP) C-reactive protein, an unspecific marker for 
inflammation (Kushner 1982). Likewise, alpha-1 
globulin consists of APPs (Kushner 1982) and its 
negative correlation with piglets’ BW, together with 
the lower plasma beta-globulin concentration in 
piglets receiving BC, might support our assump-
tion that BC supplementation might affect gut 
permeability leading to an accelerated gut closure, 
thereby reducing the risk of pathogen invasion. 
BC supplementation has been reported to improve 
sanitary status in post-weaning (Huguet et al. 
2006, 2011; Boudry et al. 2008a, 2010) and preterm 
(Moller et al. 2011) piglets. Here, we did not find 
an effect on the prevalence of diarrhea occurring 
in both treatment groups which may probably be 
associated with the relatively low BC dosage and 
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frequency. The improved WBC levels in group BC 
piglets compared to group CON piglets might be 
related to the extra micronutrients (e.g. Fe) and 
bioactive substances of the BC product used. 
Although our experimental period of 10 days was 
relatively short and BC dosage used comparatively 
small, effects on piglets’ blood parameters and 
survival could be demonstrated positively affecting 
piglet survivability, particularly in low birth weight 
piglets. However, more research is needed to eluci-
date the mode of action of BC supplementation at 
gut level in newborn pigs in the first 4 days of life.
CONCLUSION
In conclusion, data from this pilot field study 
suggest that newborn piglets’ early survival might 
be positively influenced by the BC product used, 
particularly in piglets of low birth weight. BC 
ingestion reduced plasma levels of proteins com-
pared to the control indicating an earlier intestinal 
closure. Further long-lasting studies in newborn 
piglets under experimental conditions, at least until 
weaning, are needed to clarify the exact mode of 
action of BC on (low birth weight) piglet’s survival 
and whether stronger effects may be achieved by 
a more frequent BC administration.
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